โœจ Consent to Distribution of New Medicines




756 NEW ZEALAND GAZETTE, No. 26 1 MARCH 2012

Product:
Orencia
Active Ingredient:
Abatacept 262.5mg
Dosage Form:
Powder for injection
New Zealand Sponsor:
Bristol-Myers Squibb (NZ) Limited
Manufacturer:
Bristol-Myers Squibb Holdings Pharma Limited, Manati, Puerto Rico

Product:
Velcade
Active Ingredient:
Bortezomib 1mg
Dosage Form:
Powder for injection
New Zealand Sponsor:
Janssen-Cilag (New Zealand) Limited
Manufacturer:
Ben Venue Laboratories Inc, Ohio, United States of America

Product:
Velcade
Active Ingredient:
Bortezomib 3.5mg
Dosage Form:
Powder for injection
New Zealand Sponsor:
Janssen-Cilag (New Zealand) Limited
Manufacturers:
Ben Venue Laboratories Inc, Ohio, United States of America
Pierre Fabre Medicament Production, Idron, France
BSP Pharmaceuticals SRL, Latina, Italy

Dated this 23rd day of February 2012.

Dr DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go1123

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Arrow - Amitriptyline
Active Ingredient:
Amitriptyline hydrochloride 10mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Arrow Pharmaceuticals (NZ) Limited
Manufacturer:
Ipca Laboratories Limited, Dadra and Nagar Haveli, India

Product:
Arrow - Amitriptyline
Active Ingredient:
Amitriptyline hydrochloride 25mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Arrow Pharmaceuticals (NZ) Limited
Manufacturer:
Ipca Laboratories Limited, Dadra and Nagar Haveli, India

Product:
Arrow - Amitriptyline
Active Ingredient:
Amitriptyline hydrochloride 50mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Arrow Pharmaceuticals (NZ) Limited
Manufacturer:
Ipca Laboratories Limited, Dadra and Nagar Haveli, India

Product:
Botoxยฎ
Active Ingredient:
Botulinum A toxin 200U
Dosage Form:
Powder for injection
New Zealand Sponsor:
Allergan New Zealand Limited
Manufacturer:
Allergan Pharmaceuticals Ireland, County Mayo, Ireland

Product:
Codral Relief Max Strength 6 Signs Cold & Flu
Active Ingredients:
Guaifenesin 200mg
Paracetamol 1000mg
Phenylephrine hydrochloride 12.2mg
Dosage Form:
Powder
New Zealand Sponsor:
Johnson & Johnson (New Zealand) Limited
Manufacturer:
Wrafton Laboratories Limited, Devon, United Kingdom

Product:
IPCA - Amitriptyline
Active Ingredient:
Amitriptyline hydrochloride 10mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Arrow Pharmaceuticals (NZ) Limited
Manufacturer:
Ipca Laboratories Limited, Dadra and Nagar Haveli, India



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2012, No 26





โœจ LLM interpretation of page content

๐Ÿฅ Consent to Distribution of Orencia

๐Ÿฅ Health & Social Welfare
23 February 2012
Medicines, Distribution Consent, Orencia, Abatacept
  • Dr DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health

๐Ÿฅ Consent to Distribution of Velcade

๐Ÿฅ Health & Social Welfare
23 February 2012
Medicines, Distribution Consent, Velcade, Bortezomib
  • Dr DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health

๐Ÿฅ Consent to the Distribution of New Medicines (continued from previous page)

๐Ÿฅ Health & Social Welfare
Medicines, Distribution Consent, Arrow - Amitriptyline, Botox, Codral Relief Max Strength 6 Signs Cold & Flu, IPCA - Amitriptyline